These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28756110)

  • 1. A comparative meta-analysis of neurocognition in first-degree relatives of patients with schizophrenia and bipolar disorder.
    Bora E
    Eur Psychiatry; 2017 Sep; 45():121-128. PubMed ID: 28756110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive function in euthymic bipolar disorder (BP I) patients with a history of psychotic symptoms vs. schizophrenia.
    Nenadic I; Langbein K; Dietzek M; Forberg A; Smesny S; Sauer H
    Psychiatry Res; 2015 Nov; 230(1):65-9. PubMed ID: 26319738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological risk indicators for schizophrenia: a preliminary study of female relatives of schizophrenic and bipolar probands.
    Kremen WS; Faraone SV; Seidman LJ; Pepple JR; Tsuang MT
    Psychiatry Res; 1998 Jul; 79(3):227-40. PubMed ID: 9704870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive features in clinical subgroups of bipolar disorder: A meta-analysis.
    Bora E
    J Affect Disord; 2018 Mar; 229():125-134. PubMed ID: 29306692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Chen CK; Lee CY; Lee Y; Hung CF; Huang YC; Lee SY; Huang MC; Chong MY; Chen YC; Wang LJ
    Psychiatry Res; 2018 Aug; 266():79-84. PubMed ID: 29852325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social cognition in first-degree relatives of patients with bipolar disorder: A meta-analysis.
    Bora E; Özerdem A
    Eur Neuropsychopharmacol; 2017 Apr; 27(4):293-300. PubMed ID: 28284777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder.
    Kim D; Kim JW; Koo TH; Yun HR; Won SH
    Clin Psychopharmacol Neurosci; 2015 Apr; 13(1):94-102. PubMed ID: 25912542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive performance, psychopathology and social functioning in individuals at high risk for schizophrenia or psychotic bipolar disorder.
    Gkintoni E; Pallis EG; Bitsios P; Giakoumaki SG
    J Affect Disord; 2017 Jan; 208():512-520. PubMed ID: 27810272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning of bipolar I patients and relatives from families with or without schizophrenia or schizoaffective disorder.
    Antila M; Partonen T; Kieseppä T; Suvisaari J; Eerola M; Lönnqvist J; Tuulio-Henriksson A
    J Affect Disord; 2009 Jul; 116(1-2):70-9. PubMed ID: 19117610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of neurocognition in youth with familial high risk for bipolar disorder.
    Bora E; Özerdem A
    Eur Psychiatry; 2017 Jul; 44():17-23. PubMed ID: 28531561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment in late life schizophrenia and bipolar I disorder.
    Meesters PD; Schouws S; Stek M; de Haan L; Smit J; Eikelenboom P; Beekman A; Comijs H
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):82-90. PubMed ID: 22407730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7.
    Hemager N; Plessen KJ; Thorup A; Christiani C; Ellersgaard D; Spang KS; Burton BK; Gregersen M; Søndergaard A; Greve AN; Gantriis DL; Poulsen G; Seidman LJ; Mors O; Nordentoft M; Jepsen JRM
    JAMA Psychiatry; 2018 Aug; 75(8):844-852. PubMed ID: 29926086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metacognition in psychosis: comparison of schizophrenia with bipolar disorder.
    Tas C; Brown EC; Aydemir O; Brüne M; Lysaker PH
    Psychiatry Res; 2014 Nov; 219(3):464-9. PubMed ID: 25017619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.
    Kristian Hill S; Buchholz A; Amsbaugh H; Reilly JL; Rubin LH; Gold JM; Keefe RS; Pearlson GD; Keshavan MS; Tamminga CA; Sweeney JA
    Schizophr Res; 2015 Aug; 166(1-3):310-5. PubMed ID: 26008884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia.
    Zalla T; Joyce C; Szöke A; Schürhoff F; Pillon B; Komano O; Perez-Diaz F; Bellivier F; Alter C; Dubois B; Rouillon F; Houde O; Leboyer M
    Psychiatry Res; 2004 Jan; 121(3):207-17. PubMed ID: 14675740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.